Christopher Lewis Umoja Biopharma

Chris Lewis is the Vice President of Quality for Umoja Biopharma. Prior to joining Umoja, Chris served in various Quality leadership roles at Amgen, Sandoz/Novartis, AstraZeneca Biologics, and AveXis/Novartis Gene Therapies, helping to bring life-changing clinical and commercial biologic, small molecule, and gene therapy products to patients and their families around the world. To enable the manufacture of these products, Chris has had the privilege of supporting the startup of five separate cGMP manufacturing facilities, including the honor of building of teams and organizations focused on establishing and maturing an effective quality culture and best serving one another to best serve patients together. Outside of Umoja, Chris has a passion for supporting growth in the local biotechnology community, serving as the current President of the Mountain States PDA Chapter, as a Mentor in the Colorado BioScience Institute’s Mentor Program, and facilitating Quality and Regulatory degree and certificate programs for local universities.